Search results

This paper aims to investigate the extent to which three subgroups – people with mental health conditions, people belonging to sexual minority and gender groups and Indigenous peoples – have been “left behind” by countries implementing the World Health Organization’s Framework Convention on Tobacco Control.

A general review of electronic bibliographical databases to provide an overview of smoking prevalence among the three groups and interventions designed specifically to reduce their smoking rates.

Although explanations and specific rates differ, two trends are consistent across all three groups. First, information reported in the past two decades suggests that smoking prevalence is disproportionately high among people with mental health conditions, and in the rainbow and indigenous communities. Second, most cessation programmes are targeted at majority politically dominant groups, missing opportunities to reduce smoking rates in these minority communities.

There is a general dearth of data preventing detailed analysis. Better data collection efforts are required. Trials to identify effective smoking reduction interventions for marginalised groups are needed.

It is socially unjust that these groups are being systematically ignored by tobacco control initiatives. A failure to equitably reduce tobacco harms among all groups across society has contributed to the perceived concentration of smoking in some subgroups. The increasing stigmatisation of people who smoke then adds a marginality, compounding the negative effects associated with belonging to a marginalised group. Ongoing marginalisation of these groups is an important determinant of smoking.

Cross-case analysis of neglected subgroups with disproportionately high smoking rates suggests social marginalisation is a shared and important determinant of smoking prevalence.

The study aims to provide an analytical overview of current innovations in peer review and their potential impacts on scholarly communication.

The authors created a survey that was disseminated among publishers, academic journal editors and other organizations in the scholarly communication ecosystem, resulting in a data set of 95 self-defined innovations. The authors ordered the material using a taxonomy that compares innovation projects according to five dimensions. For example, what is the object of review? How are reviewers recruited, and does the innovation entail specific review foci?

Peer review innovations partly pull in mutually opposed directions. Several initiatives aim to make peer review more efficient and less costly, while other initiatives aim to promote its rigor, which is likely to increase costs; innovations based on a singular notion of “good scientific practice” are at odds with more pluralistic understandings of scientific quality; and the idea of transparency in peer review is the antithesis to the notion that objectivity requires anonymization. These fault lines suggest a need for better coordination.

This paper presents original data that were analyzed using a novel, inductively developed, taxonomy. Contrary to earlier research, the authors do not attempt to gauge the extent to which peer review innovations increase the “reliability” or “quality” of reviews (as defined according to often implicit normative criteria), nor are they trying to measure the uptake of innovations in the routines of academic journals. Instead, they focus on peer review innovation activities as a distinct object of analysis.

This paper aims to overview the need for tobacco harm reduction, the consumer products that facilitate tobacco harm reduction and the barriers to its implementation. The worldwide endemic of tobacco smoking results in the death of over seven million smokers a year. Cigarette quit rates are very low, from 3%–12%, and relapse rates are high, from 75%–80% in the first six months and 30%–40% even after one year of abstinence. In addition, some smokers do not desire to quit. Cigarette substitution in tobacco harm reduction is one strategy that may reduce the burden of morbidity and mortality.

This review examines the displacement of smoking through substitution of non-combustible low-risk products such as snus, heated tobacco products and e-cigarettes.

Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Many barriers impede the implementation of product substitution in tobacco harm reduction. These products have been subjected to regulatory bans and heavy taxation and are rejected by smokers and society based on misperceptions about nicotine, sensational media headlines and unsubstantiated fears of youth addiction. These barriers will need to be addressed if tobacco harm reduction is to make the maximum impact on the tobacco endemic.

This review provides the rationale for tobacco harm reduction, evaluates the current products available and identifies the barriers to implementation.